Company
United StatesDaniel Claassen, M.D., Nashville, TN – FDA Inspections
Inspection records and compliance data for Daniel Claassen, M.D. in Nashville, Tennessee. 1 FDA inspection on record, last inspected September 17, 2015.
Company Profile
This profile covers Daniel Claassen, M.D. based in Nashville, Tennessee, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 1
- NAI
- 0
- Form 483s
- 0
- Warning letters
- 0
Inspected September 17, 2015.
Most cited issue areas
- Case history records- inadequate or inadequate1 inspection
- FD-1572, protocol compliance1 inspection
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| September 17, 2015 | VAI | Human Drugs · Bioresearch Monitoring | 944323 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Daniel Claassen, M.D.
FEI Number
3011703002
Address
Dept. of Neurology, Vanderbilt, Univ, 1301 Medical Center Dr Ste 3930, Nashville, Tennessee 37232, United States
Country
United States
ID: 80f99f09-ebf2-4f5e-9eb0-d55ff2dd66a4